Latest news


Health industries propose concrete measures to secure the supply chain of medicines

SICOS Press Release – 27/10/2021

For a proactive industrial policy for the pharmaceutical industry to guarantee sustainable safety and health autonomy: on the basis of a study carried out by PwC Strategy&, the health industries propose concrete measures adapted to the different types of vulnerabilities identified.

Read more


Joint statement by EFCG and BPTF on addressing the challenges of the pharmaceutical supply chain


The COVID 19 crisis has further exacerbated the structural problem which has been building up throughout the recent decade. The fact that many APIs can only be sourced outside the U.S. and Europe and that the production of some drugs (e.g., injectables) was exited years ago due to low sustainability of margins, left both continents with limited supplies of some specific but vital drugs.

Read more


Excipients – An industry adapting to change


Read more

Innovative medicines need innovative excipients

Position paper – 15/03/2021

Novel excipients are essential for the development of new medicines and vaccines. They foster patient access to innovative and affordable medicines.
Their use can also help to formulate drugs improving their efficacy, quality and safety.

Read our position paper


Kick off meeting for the Pharmaceutical Strategy for Europe


EFCG is honoured to have taken part in today’s high-profile launch of the EU Commission’s Structured Dialogue of the EU pharmaceutical strategy in the presence of Vice-president Schinas and Commissioners Kyriakides and Breton

Read our position paper